|
Re: TDM-1 results reported @ ASCO annual mtg 2012 now in New England Journal of Medic
Phil,
I have to agree another 5 to 7 years to get TDM1 approved for primary breast cancer seems unreasonable. The entire system does not favor the patient. I once argued with a fellow cancer patient who was an attorney - and lost. Seems that cancer patients and survivors should expect to be sacrificed so that the FDA can do a proper approval process.
At least I am not the only one who sees the irony in this. Are we not the ones who are supposed to be saved instead of sacrificed?
__________________
Diagnosed 2007
Stage IIb Invasive Ductal Carcinoma, Pagets, 3 of 15 positive nodes
Traditional Treatment: Mastectomy and Axillary Node Dissection followed by Taxotere, 6 treatments and 1 year of Herceptin, no radiation
Former Chemo Ninja "Takizi Zukuchiri"
Additional treatments:
GP2 vaccine, San Antonio Med Ctr
Prescriptive Exercise for Cancer Patients
ENERGY Study, UCSD La Jolla
Reconstruction: TRAM flap, partial loss, Revision
The content of my posts are meant for informational purposes only. The medical information is intended for general information only and should not be used in any way to diagnose, treat, cure, or prevent disease
Last edited by 'lizbeth; 11-09-2012 at 06:34 PM..
Reason: typo
|
Threaded Mode